| Target Price | $260.10 |
| Price | $225.37 |
| Potential |
15.41%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target IQVIA 2027 .
The average IQVIA target price is $260.10.
This is
15.41%
register free of charge
$286.65
27.19%
register free of charge
$217.15
3.65%
register free of charge
|
|
| A rating was issued by 29 analysts: 24 Analysts recommend IQVIA to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the IQVIA stock has an average upside potential 2027 of
15.41%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 15.41 | 16.35 |
| 2.81% | 6.15% | |
| EBITDA Margin | 21.96% | 23.36% |
| 3.28% | 6.37% | |
| Net Margin | 8.91% | 12.50% |
| 1.66% | 40.25% |
26 Analysts have issued a sales forecast IQVIA 2025 . The average IQVIA sales estimate is
This results in the following potential growth metrics:
25 Analysts have issued an IQVIA EBITDA forecast 2025. The average IQVIA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
27 IQVIA Analysts have issued a net profit forecast 2025. The average IQVIA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.49 | 12.01 |
| 2.74% | 60.35% | |
| P/E | 18.77 | |
| EV/Sales | 3.14 |
27 Analysts have issued a IQVIA forecast for earnings per share. The average IQVIA EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 02 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Nov 13 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 02 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Nov 13 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Oct 29 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 29 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


